Fxrα is known to regulate a variety of metabolic processes including bile acid, cholesterol and carbohydrate metabolism. In this study we show direct evidence that Fxrα is a key player in maintaining sulfate homeostasis. We identified and characterized the sodium/sulfate co-transporter (NaS-1; Slc13a1) as an Fxrα target gene expressed in the kidney and intestine. Electromobility shift assays (EMSAs), chromatin immunoprecipitation (ChIP) and promoter reporter studies identified a single functional Fxrα response element (FXRE) in the second intron of the mouse Slc13a1 gene. Treatment of wild-type mice with GW4064, a synthetic Fxrα agonist, induced Slc13a1 mRNA in the intestine and kidney. Slc13a1 mRNA was also induced in the kidney and intestine of wild-type, but not Fxrα -/-mice, after treatment with the hepatotoxin ANIT that is known to result in elevated blood bile acid levels. Finally, we observed a decrease in Slc13a1 mRNA in the kidney and intestine of Fxrα -/-mice and a corresponding increase in urinary excretion of free-sulfates as compared to wild-type mice. These results demonstrate that mouse Slc13a1 is a novel Fxrα target gene expressed in the kidney and intestine, and that in the absence of Fxrα, mice waste sulfate into the urine. Thus, Fxrα is necessary for normal sulfate homeostasis in vivo.
Fxrα is known to regulate a variety of metabolic processes including bile acid, cholesterol and carbohydrate metabolism. In this study we show direct evidence that Fxrα is a key player in maintaining sulfate homeostasis. We identified and characterized the sodium/sulfate co-transporter (NaS-1; Slc13a1) as an Fxrα target gene expressed in the kidney and intestine. Electromobility shift assays (EMSAs), chromatin immunoprecipitation (ChIP) and promoter reporter studies identified a single functional Fxrα response element (FXRE) in the second intron of the mouse Slc13a1 gene. Treatment of wild-type mice with GW4064, a synthetic Fxrα agonist, induced Slc13a1 mRNA in the intestine and kidney. Slc13a1 mRNA was also induced in the kidney and intestine of wild-type, but not Fxrα -/-mice, after treatment with the hepatotoxin ANIT that is known to result in elevated blood bile acid levels. Finally, we observed a decrease in Slc13a1 mRNA in the kidney and intestine of Fxrα -/-mice and a corresponding increase in urinary excretion of free-sulfates as compared to wild-type mice. These results demonstrate that mouse Slc13a1 is a novel Fxrα target gene expressed in the kidney and intestine, and that in the absence of Fxrα, mice waste sulfate into the urine. Thus, Fxrα is necessary for normal sulfate homeostasis in vivo.
Inorganic sulfate is one of the most abundant anions in mammalian blood and is essential for numerous physiological functions (1) . Sulfation of endogenous and exogenous substances such as steroids, neurotransmitters, xenobiotics and bile acids is a key process in their activation or detoxification of these compounds (2) . Sulfation is also essential for the biosynthesis of a variety of structural molecules such as glycosaminoglycan sulfate, cerebroside sulfate and heparin sulfate (3) .
In mammals, sulfate homeostasis is largely regulated by the kidney. The majority of filtered sulfate is reabsorbed in the proximal tubules, and only 5-20% of the filtered load is excreted into the urine (4) . Transcellular transport of sulfate from tubular lumen to blood depends on the sodium/sulfate co-transporter (NaS-1, Slc13a1) in the brush-border membrane (for sulfate entry into the cell) and a sulfate/anion exchanger (Sat-1, Slc26a1) in the basolateral membrane (for sulfate efflux into the blood) (4) . A similar transcellular transport pathway is also used in the small intestine, mainly the distal ileum, for dietary sulfate absorption (1) .
Slc13a1 was originally cloned from a rat renal cortex cDNA library using the Xenopus oocyte expression cloning system (5). This cotransporter is predominantly expressed in the renal cortex and ileum. Previous studies showed that thyroid hormone, glucocorticoids, and vitamin D can modulate serum sulfate levels, renal sulfate handling and Slc13a1 expression (6) .
Farnesoid X receptor alpha (Fxrα; NR1H4) is a ligand-activated transcription factor and a member of the nuclear receptor superfamily (7) . Fxrα binds to farnesoid X receptor response elements (FXREs) in the promoter or introns after heterodimerization with its obligate partner 9-cis retinoic acid receptor alpha (RXRα) (7, 8) . The optimal DNA binding sequence for the FXRα/RXRα heterodimer is an inverted repeat, composed of minor variants of two AGGTCA half-sites spaced by one nucleotide (IR-1) (9-11). However, FXRα/RXRα can bind to other sites, including everted and direct repeats (ER-8 and DR-1) to activate transcription (12, 13) .
In 1995, Forman et al. (10) and Seol et al. (11) identified Fxrα transcripts in the liver, kidney, intestine and the adrenal gland. In 1999, three groups independently identified bile acids as endogenous activators of Fxrα, providing critical insight into Fxrα function (14) (15) (16) . Subsequent studies have shown tissue specific expression of four distinct Fxrα isoforms (Fxrα1, Fxrα2, Fxrα3 and Fxrα4) that are derived from alternative promoters and splicing (17, 18) . Along with their tissue specific expression, certain target genes of Fxrα are regulated in an isoform-specific manner. Most of the Fxrα targets identified to date are regulated by all four Fxrα isoforms (18, 19) . However, a few of the targets are highly regulated by the Fxrα2 and Fxrα4 isoforms and relatively refractory to Fxrα1 and Fxrα3. Such genes include I-BABP, FGF-19, CryAA and SDC-1 (12, (18) (19) (20) (21) . The significance and mechanism of this isoform-specific gene activation has yet to be truly determined.
The identification of bile acids as ligands for Fxrα and the generation of potent synthetic (non-bile acid) agonists (22) (23) (24) (25) have provided significant insights into the functional role of this nuclear receptor. Fxrα has been shown to have crucial roles in controlling bile acid homeostasis, lipoprotein and glucose metabolism, hepatic regeneration, intestinal bacterial growth, response to hepatotoxins and resistance to hepatocarcinomas (19) . These studies have identified important functions for Fxrα in both the liver and intestine. In contrast, the functional importance of Fxrα in the kidney and adrenal gland is poorly understood, despite the fact that these organs express high levels of Fxrα. Recently, we and others have shown that Fxrα regulates the organic solute transporters alpha and beta (Ostα and Ostβ) in the intestine (21, (26) (27) (28) and kidney (21, 28) . These two genes are also expressed in the adrenal gland (21) . In the ileum, Ostα and Ostβ function as a heteromeric basolateral bile acid transporter that functions in the enterohepatic circulation of bile acids (29, 30) . Whether Ostα and Ostβ also affect bile acid flux through the kidney and adrenal gland remains to be determined.
In the current study, we provide direct evidence that Fxrα is a key player in the regulation of sulfate homeostasis in mice. We identified the sodium/sulfate co-transporter, Slc13a1, as a gene regulated by Fxrα in the kidney and intestine. In vivo studies show that Fxrα -/-mice display increased sulfate wasting into the urine. The data presented herein indicates that Slc13a1 is a novel Fxrα target gene in the kidney and intestine and that Fxrα is necessary to maintain the basal expression of Slc13a1, and thus normal sulfate homeostasis.
EXPERIMENTAL PROCEDURES
Materials -Expression constructs for the human FXRα1 and FXRα2 (pcDNA-hFXRα1 and pcDNA-hFXRα2) and human RXRα (pCMXhRXRα) have been described previously (20) . 3-(2,6-Dichlorophenyl)-4-(3'-carboxy-2-chlorostilben-4-yl)-oxymethyl-5-isopropyl-isoxazole (GW4064), a synthetic ligand for FXRα, was a gift from Drs Tim Willson and Patrick Malloney (GlaxoSmithKline). Alpha-naphthylisothiocyanate (ANIT) was purchased from Sigma.
RNA isolation and real-time quantitative PCR -
RNA from tissues was isolated using TRIzol reagent (Invitrogen). Real-time PCR was performed essentially as described (21) . Briefly, 5 µg of DNase I-treated total RNA from tissues was reverse-transcribed with random hexamers using SuperScript II Reverse Transcriptase (Invitrogen). Each amplification mixture (20 µl) contained 50 ng of cDNA, 375 nM forward primer, 375 nM reverse primer, and 10 µl of SYBR Green Supermix (Bio-Rad). PCR thermocycling parameters were 95°C for 2.5 min and 40 cycles of 95°C for 10 s and 60°C for 45 s. Real-time PCR was carried out using the Bio-Rad MyIQ Single Color Real-Time PCR Detection System. Each sample was assayed in duplicate and normalized to Gapdh expression. Quantitative expression values were extrapolated from separate standard curves.
Identification of a putative FXRE and EMSA -A putative FXRE in the second intron of Slc13a1 was identified using the NUBIScan computer algorithm (www.nubiscan.unibas.ch/). This approach is based on a weighted nucleotide distribution matrix compiled from published functional hexamer half sites.
Electrophoretic mobility shift assays were performed essentially as described (21) . Human FXR isoforms or human RXRα was synthesized in vitro using the TNT T7-coupled reticulocyte system (Promega). The sense strand sequence for wild-type and mutant Slc13a1 were 5'-cgagaggcccaggtcaatgtccggatggatgcc-3' (Slc13a1) and 5'-cgagaggcccagAAcaatgtTcggatggatgcc-3' (mutSlc13a1). The IR-1 is bolded and mutations are capitalized.
Chromatin immunoprecipitation -Wild-type mice were treated with either vehicle or GW4064 once a day for 5 days at 50 mg/kg, sacrificed and kidneys excised. The initial fixation of the kidneys, isolation of nuclear fraction and sonication of chromatin were performed as described (31) . Chromatin immunoprecipitation was performed using Active Motif ChIP-IT kit (Carlsbad, CA) according to the manufacture's protocol with some modifications. Briefly, the sheared chromatin was pre-cleared twice with goat IgG (20 μg) and Protein G beads and an aliquot stored to use subsequently as "input". Aliquots of the pre-cleared sheared chromatin were then immunoprecipitated using goat IgG (20 μg) or anti-FXRα antibody (C-20X; Santa Cruz, CA) (20 μg). The resulting DNA was released from protein and used for real-time quantitative PCR analysis. Quantitative PCR primers are listed in Table II .
Reporter gene and transient transfection assays -
The two copy IR-1 reporter construct (pTK-2xIR-1 WT) was generated by annealing the oligonucleotides 5'-gatcccgagaggcccaggtcaatgtccggatggatgcccgagagg cccaggtcaatgtccggatggatgcca-3' and 5'-gatctggcatccatccggacattgacctgggcctctcgggcatccat ccggacattgacctgggcctctcgg-3' before ligation into BamHI/BglII-digested TK-Luc. The two IR-1 sites are shown in boldface type. The two copy mutant IR-1 reporter construct (pTK-2xIR-1mut) was generated using the same method and the oligonucleotides 5'-gatcccgagaggcccagAAcaatgtTcggatggatgcccgaga ggcccagAAcaatgtTcggatggatgcca -3' and 5'-gatctggcatccatccgAacattgTTctgggcctctcgggcatcca tccgAacattgTTctgggcctctcgg-3'. Mutations are capitalized.
The Slc13a1 proximal promoter (-1986 to +22 relative to the transcriptional start site) was amplified from mouse genomic DNA and cloned into KpnI/NheI sites of the pGL3 basic vector (Promega) to generate pGL3-Slc13a1. The Slc13a1 (-1986 to +22) construct was amplified using the 5' primer 5'-cccggtacctgggcattttggaattatgg-3' and the 3' primer 5'-cccgctagcgagcaggtgccttcaacagt-3'.
Transient transfections were performed on 48-well plates essentially as described (21) . Briefly, 5 ng of pCMX-hRXRα, 100 ng of reporter construct, and 50 ng of pCMX-β-galactosidase, together with 50 ng of pcDNA-hFXRα1 or pcDNA-hFXRα2, were cotransfected into HepG2 cells using the MBS Mammalian Transfection Kit (Stratagene). The cells were treated with vehicle (Me 2 SO) or the indicated ligands in 10% super stripped fetal bovine serum (HyClone) for 24 h. Luciferase activity was assayed and normalized to β-galactosidase activity. Each transfection was performed in triplicate, and experiments were repeated at least three times.
Animal experiments -Eight to 10 week old male and female Fxrα -/-mice (32) and their wild-type C57BL/6J littermates were housed in a pathogenfree barrier facility with a 12 h light/12 h dark cycle and fed a standard chow diet. Where indicated, wild-type mice (4 mice/group) were gavaged twice a day for four days with either vehicle (2-hydroxypropyl-ß-cyclodextrin) or GW4064 (dissolved in vehicle) at 30 mg/kg. Animals were euthanized, and the tissues were excised and homogenized in TRIzol reagent (Invitrogen) for RNA extraction. In the initial screen (Table I) RNA was isolated from the liver, kidney and intestine of mice (two mice/group). RNA samples were subjected to real-time qPCR analysis in duplicate by Xenoport Inc (Santa Clara, CA). Subsequent analyses were performed on RNA isolated from four individual mice treated as indicated. For α-naphthylisothiocyanate (ANIT) experiment, eight to 10 week old male and female Fxrα -/-mice and their wild-type C57BL/6J littermates were gavaged a single dose of vehicle (olive oil) or ANIT dissolved in vehicle (75 mg/kg). Individual animals were placed in metabolic cages for urine collection and were provided standard chow diet and water. Animals were euthanized at 48 h after the ANIT dose and the indicated tissues were excised and homogenized in TRIzol reagent (Invitrogen) for RNA extraction. Blood was collected by cardiac puncture. Urine and serum were stored in -80° C until further use.
Measurement of serum and urinary sulfateUrinary creatinine was measured using the Prameter Creatinine Kit (R&D Systems). Inorganic sulfate levels in urine or sera were assayed by a turbidimetric method as described (33) . Briefly, urine was diluted 1:20 with 5% TCA. Serum samples were deproteinated by mixing with 10% TCA. The samples were placed on ice for 30 min, centrifuged and the sulfate present in the supernatant was collected for the assay. Standards of Na 2 SO 4 (0.5-2.0 mM for urine samples and 0.125-1.0 mM for serum samples) were prepared in 5% TCA. Fifty µl samples, standards or blanks were added to a 96-well plate in triplicate. Fifty µl of 30% glycerol were then added, covered and the mixture incubated for 10 min at room temperature. Twenty-five µl of 1% BaCl 2 in 10% dextran was then added to all wells. After the contents in the wells were mixed, the absorbance was determined using a microplate reader set at a wavelength of 600 nm. Correlation coefficient of the standard curves was >0.99. Serum and urine sulfate levels were normalized to protein and creatinine, respectively.
Statistical analysis -Mean values and SEM were determined by the analysis of multiple independent samples, each assayed in duplicate or triplicate, as indicated in the figure legends. A two-tailed Student's t-test was used to calculate P values.
RESULTS

Identification of Slc13a1 as a putative Fxrα target gene -
In an attempt to identify novel Fxrα target genes, we initially treated two wild-type mice with vehicle or the potent Fxrα agonist, GW4064 for four days. RNA was isolated from three (liver, kidney and intestine) of the four tissues that express significant levels of Fxrα. The relative expression levels of 250 known transporters and drug metabolizing enzymes were determined by real-time qPCR (see Experimental Procedures). Analysis of the data suggested that approximately 20 genes including the sodium/sulfate co-transporter (NaS-1, Slc13a1) and sulfate anion transporter (Sat-1, Slc26a1) were induced greater than 1.5 fold in the kidney, intestine or liver by GW4064 (Table I) .
In an attempt to confirm the data shown in Table I and to eliminate false positives, we treated additional wild-type mice (four mice/group) with either vehicle or GW4064 and isolated RNA from liver, kidney and intestine. RNA levels of selective genes were quantified in individual mice using real-time qPCR using primer sets (Table II) that differed from those used in the original screen. As indicated in Figure 1A and 1B, Slc13a1 message was significantly induced in the wild-type kidney and intestine in response to GW4064 (P < 0.05) whereas no discernable changes were observed with Slc26a1 mRNA expression. We conclude that the identification of Slc26a1 as a gene induced by Fxrα activation in the preliminary screen (Table I) was a false positive.
In addition to Slc13a1, a sulfotransferase (Sult2a1) and a bile acid transporter (Mrp2), two previously identified Fxrα targets involved in bile acid detoxification in the liver (13, 34) , were also induced in the kidney in response to GW4064 (Fig. 1A) . These inductions were specific since a xenobiotic sulfotransferase (Sult1a1) was not induced (Fig. 1A) . Ostα, a previously identified Fxrα target gene expressed in the kidney and intestine was induced and served as a positive control (Fig. 1A and 1B) . Moreover, qPCR analysis revealed that Slc13a1 is not expressed in the liver (data not shown).
The data in Figure 1 suggest that activation of renal Fxrα following oral administration of GW4064 induces the mRNA expression of an apical sulfate transporter, Slc13a1, as well as genes involved in bile acid sulfation and transport. In contrast, the data demonstrated that the expression of the basolateral sulfate transporter, Slc26a1, was unaffected.
Identification of an FXRE within the second intron of the mouse Slc13a1 gene -Since Slc13a1 mRNA was significantly induced in both the kidney and intestine of GW4064-treated mice, we scanned the proximal promoter of the mouse Slc13a1 gene for putative FXREs using the NUBIScan computer algorithm (see Experimental Procedures). However, no putative IR-1 was identified in the region 10 kb upstream of the mouse Slc13a1 transcription start site. Further in silico analysis of the intronic regions of the gene identified a putative IR-1 within the second intron ( Fig. 2A) . We then used in vitro-transcribed and translated RXRα and FXRα2 proteins in an electrophoretic mobility shift assay to determine whether the FXRα/RXRα heterodimer can bind to this putative FXRE. The data in Fig. 2B show that the FXRα2/RXRα heterodimer binds to radiolabeled probes containing the Slc13a1 IR-1 (Fig. 2B, lane 7) . Probes containing a wellcharacterized IR-1/FXRE from the PLTP proximal promoter (35) served as a positive control (Fig.  2B, lane 2) . In addition, unlabeled wild-type Slc13a1 IR-1 effectively competed for the binding of FXRα2/RXRα heterodimers (Fig. 2B , lanes 3-5 and 8-10), whereas the formation of the shifted complex was relatively unaffected by the presence of the unlabeled DNA containing the mutated IR-1 sequences (mutSlc13a1) (Fig. 2B, lanes 11-13) .
In order to confirm that Fxrα is associated with the putative FXRE identified in the second intron in vivo, we performed chromatin immunoprecipitation (ChIP) using DNA isolated from the kidneys of wild-type mice treated with GW4064. Chromatin was analyzed for Fxrα binding to the putative FXRE using an antibody to Fxrα and real-time qPCR primers specific for the relevant region of the second intron of the Slc13a1. A genomic region from the Slc13a1 gene, corresponding to exon 1, lacked any putative FXRE and served as a negative control (Fig. 3) . The Slc13a1 second intron DNA was enriched over 3-fold relative to an equivalent sample in which a control IgG was used in the immunoprecipitation. Fxrα binding to the negative control region of the Slc13a1 was negligible (Fig.  3) . A DNA region containing a previously identified functional FXRE from a known Fxrα target gene, Ostα, was also enriched about 4-fold relative to a control IgG (Fig. 3 ). These data demonstrate that endogenous Fxrα is specifically recruited in vivo to the region in the second intron of Slc13a1 containing the putative FXRE. Fig. 4A and 4B) . Transfection of pTK2xIR-1 WT with plasmids encoding FXRα1 or α2 and RXRα led to a robust increase in luciferase activity after the addition of GW4064 (Fig. 4A) . Importantly, mutation of the IR-1 elements (pTK2xIR-1 mut) completely abolished gene activation in response to the FXRα agonist (Fig. 4B ). These data demonstrate that the single FXRE in the second intron of Slc13a1 is critical for the transcriptional activation in response to activated Fxrα.
In order to rule out the possibility of the presence of a divergent but functional FXRE in the promoter of Slc13a1, we constructed a luciferase reporter gene 2 kb of the Slc13a1 proximal promoter (pGL3-Slc13a1-promoter). The reporter construct was transiently transfected into HepG2 cells in the presence or absence of plasmids encoding FXRα1 or FXRα2 and the cells were then incubated for 24 h with vehicle or GW4064. pGL3-Slc13a1-promoter was not induced following activation of FXRα (Fig. 4C) suggesting that the proximal promoter lacks a functional FXRE. The data demonstrate that the induction of the mouse Slc13a1 gene by FXRα activation is mediated by the FXRE identified in the second intron and not by an unidentified FXRE in the proximal promoter of the Slc13a1gene.
Measurement of urinary and serum sulfate levels of wild-type and Fxrα
-/-mice -Previous studies by Bolt et al. (36) demonstrated that vitamin D receptor null mice (Vdr -/-) exhibit a decrease in basal expression of Slc13a1 mRNA in the kidney and a corresponding decrease in renal reabsorption of free-sulfate. In addition, Dawson et al. (37) observed that in addition to an increase in urinary sulfate excretion, Slc13a1 -/-mice have increased levels of bile acids in the blood. The authors of this latter study concluded that decreased availability of free sulfates, as a result of Slc13a1 deletion, also affected bile acid homeostasis. However, the mechanism remains unknown.
Fxrα -/-mice also display increased bile acid levels in the blood (32) . Therefore, in light of the finding that Fxrα activation also regulates Slc13a1 expression, we measured free sulfate levels in urine and serum of wild-type and Fxrα -/-mice. Mice were also treated with either vehicle or α-naphthylisothiocyanate (ANIT) to further increase the overall bile acid levels in the blood. Previous work by our laboratory and others has shown that treatment of mice with ANIT increases the bile acid levels in the blood greater than 100-fold (21, 38) and this increase in bile acids result in activation of Fxrα target genes in the kidney and adrenal gland (21) . ANIT treatment likely affects other regulatory mechanisms, in addition to bile acid activation of Fxrα. Nonetheless, the increase of bile acids in the blood in ANIT-treated mice serves as an alternative approach to the use of GW4064 to activate Fxrα.
With this caveat in mind, the data in Fig. 5 show that administration of ANIT to wild-type mice resulted in a significant (P < 0.05) increase in mRNA levels of Slc13a1 in both the kidney (Fig.  5A ) and intestine (Fig. 5B) . In contrast, kidney and intestinal Slc13a1 mRNA levels were unaffected after the administration of ANIT to Fxrα -/-mice ( Fig. 5A and 5B). ANIT treatment also increased Ostα, a previously identified Fxrα target gene (21) , in the kidney and intestine of wild-type, but not Fxrα -/-, mice and served as a positive control ( Fig. 5A and 5B). Similarly, both the bile acid sulfotransferase (Sult2a1) and a bile acid transporter (Mrp2), two FXR targets involved in bile acid detoxification in the liver, were also induced in the kidney in response to ANITtreatment of wild-type mice. These changes were specific since the xenobioitic sulfotransferase (Sult1a1) was not affected by ANIT-treatment (Fig. 5A) . Unexpectedly, the kidney mRNA levels of Slc26a1, the basolateral sulfate anion transporter, were significantly inhibited in response to ANIT-treatment of wild-type mice or Fxrα -/-mice (Fig. 5A) . We conclude that administration of ANIT increased plasma bile acids that activate Fxrα in the kidney and intestine, resulting in increased transcription of Fxrα target genes that include Slc13a1, Sult2a1, Mrp2 and Ostα. Interestingly, the basal expression of Slc13a1 mRNA was significantly reduced in the Fxrα -/-as compared to wild-type mice, irrespective of the presence of ANIT (P < 0.05) (Fig. 5A and 5B). In addition, the basal expression of Slc26a1 was also significantly inhibited in the intestine of Fxrα -/-mice (P < 0.05) (Fig. 5B) . We also observed a slight reduction of Slc26a1 in the kidney from Fxrα -/-mice, although the decrease did not reach statistical significance (Fig. 5A) .
In order to determine whether the decrease in basal expression of renal Slc13a1 mRNA resulted in a corresponding decrease in renal sulfate reabsorption, we analyzed both urine and serum for free sulfate levels. Similar to Vdr -/-mice (36), Fxrα -/-mice display ~50% increase in sulfate levels in the urine (Fig. 6A) , consistent with a defect in the ability of the renal tubular cells to reabsorb free sulfates. The data suggest that the deletion of Fxrα results in a decrease in the basal expression of Slc13a1 mRNA and a corresponding increase in renal excretion of sulfates into the urine. In addition, we observed a slight reduction in serum sulfate levels in the Fxrα -/-mice, although the decrease did not reach statistical significance (P < 0.08) (Fig. 6B) . These data further suggest that the Fxrα -/-mice have adapted to the decrease in renal reabsorption of sulfates by an alternative mechanism to maintain sulfate homeostasis in the blood.
DISCUSSION
In the original studies by Forman et al. (10) , rodent Fxrα was shown to be expressed in the liver, intestine, adrenal cortex and renal tubules. Subsequent studies established that Fxrα activates hepatic and intestinal target genes involved in the maintenance bile acid, lipid and glucose homeostasis (reviewed in 19, 39, 40) . This led to the proposal that Fxrα plays a major role in the enterohepatic circulation of bile acids. Recently, organic solute transporters alpha and beta (Ostα and Ostβ) were identified as Fxrα target genes that are expressed in the adrenal gland and kidney, as well as the small intestine (21, (26) (27) (28) 41) . These data suggested a role for Fxrα in either bile acid or steroid transport in the kidney and adrenal gland. However, the physiological role and importance of Fxrα in the kidney and adrenal gland remains poorly understood, in part because very few Fxrα target genes have been identified in these two organs.
In order to identify novel Fxrα target genes, we treated wild-type mice with vehicle or GW4064 and compared the expression levels of ~250 transporters and drug metabolizing enzymes that are expressed in the kidney, liver and/or small intestine. The preliminary results suggested that only seven of the transporters, including previously identified Ostα and Ostβ, were induced in the kidneys of GW4064-treated mice (Table I) . Analysis of additional mice treated with GW4064 confirmed that the sodium/sulfate co-transporter gene (NaS-1; Slc13a1) is induced in the kidney and intestine of mice in response to Fxrα activation (Fig. 1) . The findings that Slc13a1 mRNA levels increase in an Fxrα-dependent manner in vivo, and the identification of a functional FXRE in the second intron of Slc13a1 (Figs. 2, 3 and 4) , demonstrate that Slc13a1 is a direct Fxrα target gene. In addition, we show that Fxrα plays a major role in maintaining sulfate homeostasis as Fxrα -/-mice display a decreased basal expression of Slc13a1 in the kidney (Fig.  5A ) and increased sulfate wasting into the urine (Fig. 6 ).
All cells require inorganic sulfate for normal function. Sulfate is among the most important macro-nutrients in cells and is one of the most abundant anion in human plasma (1) . Sulfate is essential for numerous physiological functions, including activation and detoxification of various endogenous and exogenous substances, including xenobiotics, steroids, neurotransmitters, and bile acids (2) . Structural molecules such as glycosaminoglycans, cerebrosides and heparin require sulfate conjugation for their biosynthesis (3) .
A number of proteins have been identified to date that transport sulfate across the cell plasma membrane. The renal proximal tubular cells express two functionally and structurally distinct sulfate transporters; the sodium/sulfate cotransporter (NaS-1; Slc13a1) and the sulfate anion transporter 1 (Sat-1; Slc26a1) (4, 6, 42) . These two transporters function to reabsorb filtered sulfate back into the blood. The most widely studied sulfate transporter, Slc13a1, is expressed mainly in the mammalian kidney and intestine. Slc13a1 is expressed on the brush border membrane of renal tubular cells and mediates the uptake of inorganic sulfate that has been filtered through the glomeruli. The inorganic sulfates that have been taken up by Slc13a1 are returned to the blood by Slc26a1 expressed on the basolateral membrane of renal tubular cells thus maintaining sulfate homeostasis in the blood. Both Slc13a1 and Slc26a1 are also expressed in the intestine (43) , where it has been proposed that these two proteins may function to absorb dietary sulfates.
The importance of Slc13a1 in sulfate homeostasis is well established. Mice deficient in Slc13a1 (Slc13a1 -/-) display hyposulfatemia as a result of decreased renal sulfate reabsorption (37) . In addition, these mice have major physiological defects such as growth retardation, reduced fertility and spontaneous seizures (37) . Additional studies have shown that the Slc13a1 gene is regulated at the transcriptional level by the activation of the vitamin D receptor (Vdr) and thyroid hormone receptor (44) , two members of the nuclear receptor family. The response elements in the promoter region of the mouse Slc13a1 gene that interact with these two nuclear receptors have been identified (44) . In addition, the relative importance of Vdr in the maintenance of sulfate homeostasis has been established as mice deficient in Vdr display increased sulfate excretion into the urine and a concurrent decrease in serum sulfate levels (36) . The observed hyposulfatemic phenotype in the Vdr -/-mice is attributed to a decrease in the basal expression of Slc13a1 as compared to wild-type mice (36) .
In the current study, we report similar changes in Slc13a1 mRNA expression and sulfate levels in the urine and serum of Fxrα -/-mice as was previously observed in Vdr -/-mice (36) . We show that the Slc13a1 gene is regulated at the transcriptional level by the nuclear receptor Fxrα. Deficiency in Fxrα leads to a decrease in the basal expression of Slc13a1 mRNA (Fig. 5) . More importantly, as a result of this decrease, there is an increase in the excretion of sulfates into the urine and a decrease in serum sulfate (Fig. 6) , indicating a defect in sulfate reaborption by renal tubular cells. The reduction of sulfate levels in the serum of Fxrα -/-mice, however, did not reach statistical significance (Fig. 6B) . It is tempting to speculate that there are compensatory mechanisms that could induce metabolism of amino acids or sulfated macromolecules that allow for the maintenance of relatively normal sulfate levels in the blood (1). Taken together with previous studies, we conclude that Slc13a1 expression and sulfate homeostasis is controlled in vivo by both Vdr and Fxrα.
The importance of Fxrα activation as opposed to loss of Fxrα, in maintaining sulfate homeostasis remains unclear. Although activation of Fxrα either by a synthetic agonist (Fig. 1) or by increased availability of bile acids (Fig. 5) can lead to the up-regulation of Slc13a1 mRNA, our data suggest that the increase in message has no significant effect on blood or urine sulfate levels (data not shown). The data in Figure 5 suggest that increased bile acid levels in the renal tubular cells induce the expression of Slc13a1 by activation of Fxrα, thus increasing the availability of inorganic sulfates in the renal tubular cells. Since the accumulation of bile acids is toxic, the renal tubular cells may utilize the increased sulfate pool as a detoxification process to eliminate bile acids into the urine. Consistent with this hypothesis, we observed an increase in the expression of both a bile acid sulfotransferase (Sult2a1) and a bile acid transporter (Mrp2) in the kidney in response ANIT (Fig. 5A ). In addition, we also observed a downregulation of Slc26a1 mRNA, the basolateral sulfate transporter, in response to ANIT (Fig. 5A) . In contrast to Slc13a1, the transcriptional regulation of Slc26a1 remains to be established. Nevertheless, such "contra-regulation" of the two sulfate transporters (increase in Slc13a1 and decrease in Slc26a1) in response to bile acids may be required to retain sulfates in the renal tubular cells to be utilized for bile acid detoxification. Such sulfated and conjugated bile acids might then be excreted into the urine rather than being transported into the blood where bile acids are already at supra-physiological levels as a result of the ANIT treatment. However, additional studies will be necessary to determine whether the repression of Slc26a1, observed in the kidneys of ANIT-treated mice, is a result of the toxic side effects of the drug.
Similar to the kidney, Slc13a1 mRNA levels are induced in the intestine of mice in response to Fxrα activation (Fig. 1B and 5B). Intestinal Slc13a1 is thought to mediate the absorption of dietary sulfates (43) . Further analysis will be required to determine if reduced expression of intestinal Slc13a1 message in the Fxrα -/-mice is associated with changes in absorption of dietary sulfates.
In summary, the current study identifies the sodium/sulfate co-transporter, Slc13a1 that is expressed in the kidney and intestine, as a novel Fxrα target gene. The expression and regulation of Slc13a1 in the kidney is disrupted in Fxrα -/-mice. Such changes are associated with increased excretion of inorganic sulfates into the urine. The findings of this study implicate a novel role for Fxrα in sulfate homeostasis.
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We thank Dr Frank Gonzalez (NIH) for initially providing Fxrα +/-mice. This work was supported by National Institutes of Health Grants HL-68445 and HL-30568 (to P.A.E.), a grant from the Laubisch Fund (to P.A.E). Fig. 1 . GW4064 treatment induces Slc13a1 mRNA in the kidney and intestine of wild-type mice. Wild-type mice (four mice/group) were orally gavaged twice daily for 4 days with vehicle or GW4064 (30 mg/kg). Total RNA was isolated from kidney (A) and intestine (B) and reverse-transcribed for realtime quantitative PCR analysis using the indicated gene-specific primers (Table II) . Samples from each mouse were assayed in duplicate and normalized to murine GAPDH. Data are reported as mean ± SEM (n=4); *P < 0.05. Wild-type mice were orally gavaged once daily for five days with vehicle or GW4064 (50 mg/kg). Chromatin immunoprecipitation was performed as described in Experimental Procedures. Chromatin was immunoprecipitated with either control goat IgG or anti-FXRα antibody followed by real-time quantitative PCR analysis of the precipitated DNA using primers for Slc13a1, Ostα, or a genomic region of Slc13a1 (exon 1) as negative control. * P < 0.05. (-1986 to +22 relative to the transcriptional start site; pGL3-Slc13a1-promoter) (C). The cells were also cotransfected with β-galactosidase, RXRα, and either FXRα1 or FXRα2. Following treatment for 48 h with either vehicle (DMSO) or 1µM GW4064, cells were lysed and luciferase activity determined, normalized to β-galactosidase activity and expressed as relative light units (RLU). All transfections were performed in triplicate, and the data are given as means ± SEM. The data shown are representative of at least two experiments. * P < 0.05. 
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